Bioscientia Institut für Medizinische Diagnostik GmbH is a prominent diagnostic laboratory service provider based in Germany. The company specializes in examining biomarkers, pathogens, gene sequences, and trace elements from various body materials. With a network of 25 locations in Germany, Bioscientia receives approximately 100,000 samples daily from physicians of all specialties. The company's highly trained laboratory teams employ both conventional and cutting-edge techniques for analysis, supported by expert consultation from physicians and scientists. Additionally, Bioscientia offers tailored on-site laboratory and reference shipping solutions, as well as IT connectivity and Point-of-Care concepts for healthcare facilities. Having a significant presence within Sonic Healthcare, Bioscientia benefits from global access to in-vitro experts, enabling them to leverage rapid advancements for their clients and partners. Moreover, the company acknowledges the importance of nurturing future talent for the evolving landscape of digital medicine, offering its own educational programs to meet these needs. With a focus on utilizing data and fostering dialogue toward accurate diagnoses, Bioscientia Institut für Medizinische Diagnostik GmbH continues to be a key player in the field, providing invaluable services to physicians and clinics.
There is no investment information
No recent news or press coverage available for Bioscientia.